Watson 371 25 mg Pill - green & white capsule/oblong, 18mm
Pill with imprint Watson 371 25 mg is Green & White, Capsule/Oblong and has been identified as Loxapine Succinate 25 mg. It is supplied by Watson Laboratories, Inc.
Loxapine is used in the treatment of Agitation; Schizophrenia; Agitated State and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 371 25 mg
Loxapine Succinate
- Imprint
- Watson 371 25 mg
- Strength
- 25 mg
- Color
- Green & White
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antipsychotic agents
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
-
lactose anhydrous,
benzyl alcohol,
butylparaben,
edetate calcium disodium,
gelatin,
magnesium stearate,
methylparaben,
polacrilin potassium,
propylparaben,
sodium lauryl sulfate,
sodium propionate,
magnesium silicate,
titanium dioxide,
D&C Yellow No. 10,
FD&C Blue No. 1
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00591-0371 | Watson Pharmaceuticals, Inc. |
| 51079-0902 (Discontinued) | UDL Laboratories Inc. |
More about loxapine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (22)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antipsychotic agents
- Breastfeeding
- En español
Patient resources
- Loxapine drug information
- Loxapine (Inhalation) (Advanced Reading)
- Loxapine (Oral) (Advanced Reading)
- Loxapine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.